The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

被引：431
作者：
Cookson, Mark R. [1 ]
机构：
[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20982 USA
来源：
NATURE REVIEWS NEUROSCIENCE | 2010年 / 11卷 / 12期
基金：
美国国家卫生研究院;
关键词：
AUTOSOMAL-DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LEUCINE-RICH-REPEAT-KINASE-2; LRRK2; CYTOPLASMIC LOCALIZATION; 14-3-3; BINDING; ROC DOMAIN; MUTATIONS; PROTEIN; PHOSPHORYLATION; GENE;
D O I：
10.1038/nrn2935
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene-leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically a-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.
引用
收藏
页码：791 / 797
页数：7
相关论文
共 74 条
[11]   Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization [J].
Dzamko, Nicolas ;
Deak, Maria ;
Hentati, Faycal ;
Reith, Alastair D. ;
Prescott, Alan R. ;
Alessi, Dario R. ;
Nichols, R. Jeremy .
BIOCHEMICAL JOURNAL, 2010, 430 :405-413
[12]   An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family [J].
Funayama, M ;
Hasegawa, K ;
Ohta, E ;
Kawashima, N ;
Komiyama, M ;
Kowa, H ;
Tsuji, S ;
Obata, F .
ANNALS OF NEUROLOGY, 2005, 57 (06) :918-921
[13]   A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1 [J].
Funayama, M ;
Hasegawa, K ;
Kowa, H ;
Saito, M ;
Tsuji, S ;
Obata, F .
ANNALS OF NEUROLOGY, 2002, 51 (03) :296-301
[14]   LRRK2 expression linked to dopamine-innervated areas [J].
Galter, D ;
Westerlund, M ;
Carmine, A ;
Lindqvist, E ;
Sydow, O ;
Olson, L .
ANNALS OF NEUROLOGY, 2006, 59 (04) :714-719
[15]   The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules [J].
Gandhi, Payal N. ;
Wang, Xinglong ;
Zhu, Xiongwei ;
Chen, Shu. G. ;
Wilson-Delfosse, Amy L. .
JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (08) :1711-1720
[16]   Molecular pathogenesis of Parkinson disease: insights from genetic studies [J].
Gasser, Thomas .
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11
[17]   Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression [J].
Gehrke, Stephan ;
Imai, Yuzuru ;
Sokol, Nicholas ;
Lu, Bingwei .
NATURE, 2010, 466 (7306) :637-U9
[18]   Common LRRK2 mutation in idiopathic Parkinson's disease [J].
Gilks, WP ;
Abou-Sleiman, PM ;
Gandhi, S ;
Jain, S ;
Singleton, A ;
Lees, AJ ;
Shaw, K ;
Bhatia, KP ;
Bonifati, V ;
Quinn, NP ;
Lynch, J ;
Healy, DG ;
Holton, JL ;
Revesz, T ;
Wood, NW .
LANCET, 2005, 365 (9457) :415-416
[19]   Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration? [J].
Gillardon, Frank .
JOURNAL OF NEUROCHEMISTRY, 2009, 110 (05) :1514-1522
[20]   Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2 [J].
Gloeckner, Christian Johannes ;
Boldt, Karsten ;
von Zweydorf, Felix ;
Helm, Sandra ;
Wiesent, Ludwig ;
Sarioglu, Hakan ;
Ueffing, Marius .
JOURNAL OF PROTEOME RESEARCH, 2010, 9 (04) :1738-1745
12345678